CD274 structural variants for guiding treatment with PD-1 blockade in a patient with relapsed/refractory chronic active EBV transformed to NK lymphoma

This publication has 15 references indexed in Scilit:

• Non-invasive plasma testing for CD274 UTR structural variations by next-generation sequencing in cancer
  Cell Death Discovery, 2023
• The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms
  Leukemia, 2022
• Characteristics of Epstein–Barr virus reactivation after allogeneic haematopoietic stem cell transplantation in patients with chronic active Epstein–Barr virus disease: favorable responses to rituximab
  Bone Marrow Transplantation, 2021
• Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma
  Leukemia, 2020
• MicroRNA‐155‐5p suppresses PD‐L1 expression in lung adenocarcinoma
  FEBS Open Bio, 2020
• Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas
  Leukemia, 2019
• Novel genomic findings in multiple myeloma identified through routine diagnostic sequencing
  Journal of Clinical Pathology, 2018
• Aberrant PD-L1 expression through 3′-UTR disruption in multiple cancers
  Nature, 2016
• PD-L1 Expression Is Characteristic of a Subset of Aggressive B-cell Lymphomas and Virus-Associated Malignancies
  Clinical Cancer Research, 2013
• Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States
  Blood, 2011